Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jan

Showing results (221-230 of 255) with videos related to

Pageof 26
Sort By:
Annals of Surgery|June 30, 2021
Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysisBerend J van der Wilk, Ben M Eyck, Wayne L Hofstetter, et al.
The Journal of Pathology|October 5, 2022
Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancerBen M Eyck, Maurice Phm Jansen, Bo Jan Noordman, et al.
BMC Cancer|April 10, 2023
A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2Charlène J van der Zijden, Sjoerd M Lagarde, Merel Hermus, et al.
Nuclear Medicine Communications|May 3, 2023
External validation of 18 F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapyMaria J Valkema, Roelof J Beukinga, Avishek Chatterjee, et al.
The New England Journal of Medicine|November 22, 2002
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagusJan B F Hulscher, Johanna W van Sandick, Angela G E M de Boer, et al.
International Journal of Cancer|June 18, 2026
Total Neoadjuvant Treatment for Esophageal Adenocarcinoma With Oligometastases: TNT-OES-1 TrialCharlène J van der Zijden, Tamara J Huizer, Ben M Eyck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2019
Accuracy of <sup>18</sup>F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerMaria J Valkema, Bo Jan Noordman, Bas P L Wijnhoven, et al.
Nuclear Medicine Communications|November 20, 2023
18 F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapyMaria J Valkema, Quido G de Lussanet de la Sablonière, Roelf Valkema, et al.
Journal of Carcinogenesis|June 19, 2015
Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinomaAnna M J van Nistelrooij, Hetty A G M van der Korput, Linda Broer, et al.
Endoscopy|December 21, 2025
The value of routine endoscopic ultrasound in patients with esophageal cancer after neoadjuvant chemoradiotherapy undergoing active surveillanceSanjiv S G Gangaram Panday, Matteo Pittacolo, Sjoerd Lagarde, et al.
Pageof 26

Showing results (221-230 of 255) with videos related to

Sort By:
Pageof 26
Annals of Surgery|June 30, 2021
Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysisBerend J van der Wilk, Ben M Eyck, Wayne L Hofstetter, et al.
The Journal of Pathology|October 5, 2022
Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancerBen M Eyck, Maurice Phm Jansen, Bo Jan Noordman, et al.
BMC Cancer|April 10, 2023
A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2Charlène J van der Zijden, Sjoerd M Lagarde, Merel Hermus, et al.
Nuclear Medicine Communications|May 3, 2023
External validation of 18 F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapyMaria J Valkema, Roelof J Beukinga, Avishek Chatterjee, et al.
The New England Journal of Medicine|November 22, 2002
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagusJan B F Hulscher, Johanna W van Sandick, Angela G E M de Boer, et al.
International Journal of Cancer|June 18, 2026
Total Neoadjuvant Treatment for Esophageal Adenocarcinoma With Oligometastases: TNT-OES-1 TrialCharlène J van der Zijden, Tamara J Huizer, Ben M Eyck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2019
Accuracy of <sup>18</sup>F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerMaria J Valkema, Bo Jan Noordman, Bas P L Wijnhoven, et al.
Nuclear Medicine Communications|November 20, 2023
18 F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapyMaria J Valkema, Quido G de Lussanet de la Sablonière, Roelf Valkema, et al.
Journal of Carcinogenesis|June 19, 2015
Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinomaAnna M J van Nistelrooij, Hetty A G M van der Korput, Linda Broer, et al.
Endoscopy|December 21, 2025
The value of routine endoscopic ultrasound in patients with esophageal cancer after neoadjuvant chemoradiotherapy undergoing active surveillanceSanjiv S G Gangaram Panday, Matteo Pittacolo, Sjoerd Lagarde, et al.
Pageof 26